Page 1 of Clinical Trials for Viral Vaccines, 2287 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Chikungunya Virus Vaccine Trial in Healthy Adults
Last Updated: March 20, 2012
Condition(s): Chikungunya Virus; Vaccines, Virus-like Particles; Viral Vaccines; Humoral Immunity; Chikungunya Fever
2
Terminated
Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
Last Updated: June 19, 2009
Condition(s): Colorectal Cancer; Lung Cancer
3
Completed
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
Last Updated: July 31, 2010
Condition(s): Prostate Cancer
4
Withdrawn
Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission
Last Updated: January 30, 2008
Condition(s): Breast Cancer
5
Completed
A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children
Last Updated: May 17, 2012
Condition(s): HIV Infections
6
Completed
A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules
Last Updated: May 22, 2012
Condition(s): HIV Infections; HIV Seronegativity
7
Completed
A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers
Last Updated: September 24, 2007
Condition(s): HIV Infections
8
Completed
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals
Last Updated: May 17, 2012
Condition(s): HIV Infections
9
Completed
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules
Last Updated: April 26, 2012
Condition(s): HIV Infections
10
Completed
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose
Last Updated: April 26, 2012
Condition(s): HIV Infections
11
Completed
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)
Last Updated: May 23, 2012
Condition(s): HIV Infections
12
Active, not recruiting
Kidney Transplants in People With HIV Infection
Last Updated: September 26, 2008
Condition(s): HIV Infections; End-Stage Renal Disease
13
Completed
Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults
Last Updated: May 16, 2012
Condition(s): HIV Infections
14
Completed
A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (VaxSyn)
Last Updated: May 22, 2012
Condition(s): HIV Infections
15
Completed
The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV
Last Updated: December 21, 2009
Condition(s): HIV Infections
16
Completed
A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines
Last Updated: May 23, 2012
Condition(s): HIV Infections
17
Completed
A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals
Last Updated: May 22, 2012
Condition(s): HIV Infections
18
Completed
A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160
Last Updated: May 23, 2012
Condition(s): HIV Infections
19
Completed
A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
Last Updated: June 23, 2005
Condition(s): HIV Infections; HIV Seronegativity
20
Completed
A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)
Last Updated: May 16, 2012
Condition(s): HIV Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Viral+Vaccines

Page 1 of Clinical Trials for Viral Vaccines, 2287 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About